Chiranjibi Chhotaray Selected Research

Chiranjibi Chhotaray Research Topics

6	Tuberculosis (Tuberculoses) 07/2020 - 01/2017
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020 - 11/2019
1	Infections 01/2022
1	Extensively Drug-Resistant Tuberculosis 01/2020
1	Inflammation (Inflammations) 01/2019

2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 07/2020
2	Amikacin (A.M.K)FDA LinkGeneric 07/2020 - 01/2020
1	Imipenem FDA Link 01/2022
1	Rifabutin (Ansamycin)FDA Link 01/2022
1	Linezolid (Zyvox)FDA Link 01/2022
1	Streptomycin (Streptomycin Sulfate)FDA Link 07/2020
1	Pyrazinamide FDA LinkGeneric 01/2020
1	Levofloxacin (Levaquin)FDA Link 11/2019
1	Moxifloxacin (Avelox)FDA Link 11/2019
1	mycolactoneIBA 01/2019
1	Kanamycin FDA Link 01/2017

2	Therapeutics 01/2018 - 01/2017
1	Injections 01/2020